Awards

Cure Alzheimer's Fund Featured in 2016 Holiday Giving Guide

In findings published on The Beacon, Cure Alzheimer’s Fund was selected among 11 charities for The Beacon's 2016 Holiday Gift Guide.

Beacon analysts obtained data from charitynavigator.org, where Cure Alzheimer’s Fund scores a perfect 100 points. As of December 2016, the nonprofit had distributed over $48 million to Alzheimer's research.

Cure Alzheimer’s Fund Receives 100 Percent Rating from Charity Navigator

Organization achieves 4-star rating for 5th consecutive time

(Wellesley, MA) – June 2016 – Cure Alzheimer’s Fund is announcing that Charity Navigator has assigned the organization a score of 100 percent regarding its overall financial health. The nation's largest and most-utilized evaluator of charities, Charity Navigator assigned this score by evaluating two areas of the Fund’s performance – financial health and accountability/transparency – through the IRS Form 990.

Drs. Rudy Tanzi and Doo Yeon Kim Receive Smithsonian Ingenuity Award

Cure Alzheimer’s Fund is thrilled to extend our congratulations to the chair of our Research Consortium, Dr. Rudy Tanzi, and to Dr. Doo Yeon Kim, for receiving the prestigious Smithsonian Magazine American Ingenuity Award.

David Holtzman, M.D., Receives Faculty Achievement Award

David Holtzman, M.D., member of the Cure Alzheimer’s Fund Research Consortium, will receive the 2015 Carl and Gerty Cori Faculty Achievement Award from his home institution, Washington University in St. Louis. The award goes to faculty members who “embody the ideals of individual and collaborative excellence” and “have made significant contributions to their fields,” according to Washington University Chancellor Mark S. Wrighton.

Rudy Tanzi, Ph.D., Named One of TIME's 100 Most Influential People of 2015

Rudy Tanzi, Ph.D., chair of the Cure Alzheimer's Fund Research Consortium, was named one of TIME Magazine's '100 Most Influential People of 2015' in a list published earlier this week.

Tanzi has long been known for his pioneering work in Alzheimer's disease research, especially Alzheimer's genetics. He made an especially important contribution to the field in 2014 with his lab's "Alzheimer's in a Dish" breakthrough, a tool that will be used to enhance our understanding of the disease and accelerate drug discovery.

Cure Alzheimer’s Fund Receives 4th Consecutive 4-Star Rating on Charity Navigator

For the fourth year in a row, Cure Alzheimer’s Fund has received a 4-star rating – the highest possible – from watchdog organization Charity Navigator. Charity Navigator rates over 8,000 nonprofits on many aspects of their accountability, transparency and fiscal responsibility.

Academy Awards 2015: Julianne Moore on Alzheimer's

Julianne Moore--interview----Oscars 2015 HD

Actress Julianne Moore, star of Still Alice, discusses the problem of Alzheimer's with red carpet interviewer Robin Roberts at the 2015 Academy Awards. Moore later received the Academy Award for Best Actress for her role in the film.

Still Alice, based on the novel of the same name by Lisa Genova, follows professor Alice Howland (Moore) after she is diagnosed with early-onset Alzheimer's disease. Howland struggles to maintain her career and her relationships with family members as her symptoms worsen.

Honoring Charles Collier, Alzheimer's Advocate

Honoring Charles Collier

At Cure Alzheimer's Fund's 10th anniversary celebration, we honored Alzheimer's advocate Charles Collier for his incredible work fighting the stigma surrounding Alzheimer's disease. Collier is a former senior philanthropic advisor to Harvard University who was diagnosed with early onset AD in 2008. His successor at Harvard, Mr. Alastair Halliday, provided some congratulatory remarks.

Learn more about Collier and his work here.

16 Cure Alzheimer’s Fund Scientists Listed Among World’s Most Influential

A prestigious new list of the "World's Most Influential Scientific Minds" includes 16 scientists closely associated with Cure Alzheimer's Fund.

Dr. Thomas Südhof Wins Nobel Prize

Our congratulations to Dr. Thomas C. Sϋdhof of Stanford University, a member of Cure Alzheimer’s Fund's Research Consortium, who joins Randy Scheckman of the University of California, Berkeley and James E. Rothman of Yale University in winning the Nobel Prize in Physiology or Medicine as announced today.